Status:
RECRUITING
Renal Stone Treatment Global Registry
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Urolithiasis
Eligibility:
All Genders
18+ years
Brief Summary
This is an international prospective data registry to assess the treatment outcomes and complications of different treatment approaches for different surgical treatment of urolithiasis.
Detailed Description
Renal stone is a common condition, and many patients suffered from recurrent diseases and required multiple interventions in their lifetime. Currently, there are many treatment options available for s...
Eligibility Criteria
Inclusion
- Patient at the age of 18 or above
Exclusion
- Patient is unable to give consent
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2033
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT05297331
Start Date
March 1 2022
End Date
March 31 2033
Last Update
April 1 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Alice Ho Miu Ling Nethersole Hospital
Hong Kong, Hong Kong
2
Prince of Wales Hospital
Shatin, Hong Kong
3
North District Hospital
Sheung Shui, Hong Kong